Leap Therapeutics Presents Biomarker Data from Clinical Study of DKN-01 in Combination with Paclitaxel in Esophageal Cancer

Stock Information for Macrocure Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Macrocure Ltd.

Macrocure and Leap Therapeutics Complete Merger
Macrocure Announces New Date for Special General Meeting of Shareholders to Approve Merger With Leap Therapeutics
Macrocure Announces Special General Meeting of Shareholders to Approve Merger With Leap Therapeutics
Leap Therapeutics and Macrocure Announce Definitive Merger Agreement
Stocks To Watch: Investors Are Considering These on Monday April 25th
Macrocure Files Annual Report on Form 20-F for the Year Ended December 31, 2015
Macrocure Announces Receipt of NASDAQ Minimum Bid Price Notification
Macrocure Announces Annual General Meeting of Shareholders

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.